$PZG
Paramount Gold Nevada Corp

2020 Q1 Form 10-Q Financial Statement

#000156459020022350 Filed on May 07, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q3 2019 Q1
Revenue $391.5K $31.36K $212.7K
YoY Change 84.02% -70.0% 855.73%
Cost Of Revenue $131.6K $137.6K $130.6K
YoY Change 0.83% -14.01% 8.79%
Gross Profit $259.9K -$106.2K $82.20K
YoY Change 216.13% 77.03% -182.2%
Gross Profit Margin 66.38% -338.72% 38.64%
Selling, General & Admin $417.1K $344.5K $471.2K
YoY Change -11.48% -21.71% 4.71%
% of Gross Profit 160.51% 573.21%
Research & Development $1.068M $458.6K $712.6K
YoY Change 49.87% -2.43% -32.13%
% of Gross Profit 411.0% 866.93%
Depreciation & Amortization $650.00 $460.00 $650.00
YoY Change 0.0%
% of Gross Profit 0.25% 0.79%
Operating Expenses $1.711M $862.4K $1.392M
YoY Change 22.98% -12.89% -11.37%
Operating Profit -$1.320M -$992.2K -$1.179M
YoY Change 11.97% -5.5% -29.22%
Interest Expense -$120.5K $15.76K $5.400K
YoY Change -2331.48% -46.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$1.440M -$1.006M -$1.173M
YoY Change 22.75% -4.95% -29.31%
Income Tax
% Of Pretax Income
Net Earnings -$1.440M -$1.006M -$1.173M
YoY Change 22.75% -4.95% -29.26%
Net Earnings / Revenue -367.92% -3209.6% -551.56%
Basic Earnings Per Share -$0.04 -$0.04
Diluted Earnings Per Share -$51.86K -$0.04 -$0.04
COMMON SHARES
Basic Shares Outstanding 27.08M
Diluted Shares Outstanding 27.08M

Balance Sheet

Concept 2020 Q1 2019 Q3 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.414M $4.188M $362.0K
YoY Change 290.71% 166.73% -74.33%
Cash & Equivalents $1.414M $4.188M $362.0K
Short-Term Investments
Other Short-Term Assets $770.9K $1.649M $412.3K
YoY Change 86.95% 199.77% 37.44%
Inventory
Prepaid Expenses
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $2.185M $5.836M $774.3K
YoY Change 182.21% 175.3% -55.24%
LONG-TERM ASSETS
Property, Plant & Equipment $47.06M $5.839K $48.87M
YoY Change -3.69% -99.99% -0.01%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $693.0K $1.383M $1.408M
YoY Change -50.77% -17.68% -29.61%
Total Long-Term Assets $47.76M $48.44M $50.28M
YoY Change -5.01% -4.17% -1.17%
TOTAL ASSETS
Total Short-Term Assets $2.185M $5.836M $774.3K
Total Long-Term Assets $47.76M $48.44M $50.28M
Total Assets $49.94M $54.28M $51.05M
YoY Change -2.17% 3.06% -2.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $627.0K $784.5K $656.1K
YoY Change -4.43% 45.27% -0.59%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $724.3K $881.8K $757.7K
YoY Change -4.41% 37.77% -5.29%
LONG-TERM LIABILITIES
Long-Term Debt $5.239M $5.204M $0.00
YoY Change
Other Long-Term Liabilities $216.1K $866.3K $704.1K
YoY Change -69.31% -4.8% -38.24%
Total Long-Term Liabilities $5.455M $6.071M $704.1K
YoY Change 674.79% 567.12% -38.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $724.3K $881.8K $757.7K
Total Long-Term Liabilities $5.455M $6.071M $704.1K
Total Liabilities $6.179M $6.953M $1.462M
YoY Change 322.73% 345.67% -24.26%
SHAREHOLDERS EQUITY
Retained Earnings -$48.71M
YoY Change
Common Stock $96.03M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $43.76M $47.33M $49.59M
YoY Change
Total Liabilities & Shareholders Equity $49.94M $54.28M $51.05M
YoY Change -2.17% 3.06% -2.95%

Cashflow Statement

Concept 2020 Q1 2019 Q3 2019 Q1
OPERATING ACTIVITIES
Net Income -$1.440M -$1.006M -$1.173M
YoY Change 22.75% -4.95% -29.26%
Depreciation, Depletion And Amortization $650.00 $460.00 $650.00
YoY Change 0.0%
Cash From Operating Activities -$591.7K -$1.478M -$899.1K
YoY Change -34.19% -10.03% -36.24%
INVESTING ACTIVITIES
Capital Expenditures -$1.280K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$1.280K $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 5.202M 960.9K
YoY Change -100.0% 78.68%
NET CHANGE
Cash From Operating Activities -591.7K -1.478M -899.1K
Cash From Investing Activities -1.280K 0.000 0.000
Cash From Financing Activities 0.000 5.202M 960.9K
Net Change In Cash -593.0K 3.724M 61.79K
YoY Change -1059.7% 193.56% -101.62%
FREE CASH FLOW
Cash From Operating Activities -$591.7K -$1.478M -$899.1K
Capital Expenditures -$1.280K $0.00
Free Cash Flow -$590.4K -$899.1K
YoY Change -34.33% -190.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
23648
CY2019Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
41376
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
1711358
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1440372
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1173413
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4789388
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3662629
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
49196107
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1725
CY2019Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
8069
CY2020Q1 pzg Interest And Service Charges
InterestAndServiceCharges
122231
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
1391555
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1319866
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1178809
CY2019Q1 pzg Interest And Service Charges
InterestAndServiceCharges
2673
CY2019Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
976144
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
us-gaap Net Income Loss
NetIncomeLoss
-4789388
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27489446
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
66668
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
20000
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
943992
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.38
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.74
CY2019 pzg Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
2911286
CY2019 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
960870
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5970048
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
67506
CY2020Q1 pzg Stock Issued During Period Value Payment Of Interest Accrued
StockIssuedDuringPeriodValuePaymentOfInterestAccrued
119309.00
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1440372
us-gaap Profit Loss
ProfitLoss
-4789388
us-gaap Profit Loss
ProfitLoss
-3662629
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
976144
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
127012
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
182012
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
37225
pzg Interest Expense Income
InterestExpenseIncome
-102425
pzg Interest Earned On Reclamation Bond
InterestEarnedOnReclamationBond
14447
pzg Interest Earned On Reclamation Bond
InterestEarnedOnReclamationBond
29296
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-16292
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
422089
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
168205
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-131540
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-271841
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4246470
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3807568
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
4719
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4719
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2911286
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
5201807
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
960870
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5201807
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3872156
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
950618
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
64588
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
463690
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
297389
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1414308
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
361977
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27489446
us-gaap Net Income Loss
NetIncomeLoss
-3662629
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25634878
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25634878
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
28310
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1006499
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
47327697
CY2019Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31196
pzg Sale Of Equity Units Description Of Transaction
SaleOfEquityUnitsDescriptionOfTransaction
Each unit consisted of one share of common stock and one warrant to purchase one-half of a share of common stock.
CY2019Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
1.25
pzg Class Of Warrant Or Right Description
ClassOfWarrantOrRightDescription
Each warrant has a two-year term and will be exercisable at the following exercise prices: in the first year at $1.30 per share and in the second year at $1.50 per share
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
690000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of these interim condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated interim financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant estimates made by management in the condensed consolidated interim financial statements include the adequacy of the Company&#8217;s reclamation and environmental obligation, share based compensation, warrant valuation, valuation of deferred tax assets and liabilities, and assessment of impairment of mineral properties.</p>
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
0.74
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash and cash equivalents.&nbsp;&nbsp;The Company maintains cash and cash equivalents in accounts which may, at times, exceed federally insured limits.&nbsp;&nbsp;At March 31, 2020, the Company had $1.41 million of balances in excess of federally insured limits.&nbsp;&nbsp;We deposit our cash with financial institutions which we believe have sufficient credit quality to minimize the risk of loss.</p>
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.51
CY2020Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
229983
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y1M9D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
49408
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
69628
CY2019Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
965677
CY2018Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
1072551
pzg Cash Uninsured Amount Description
CashUninsuredAmountDescription
We deposit our cash with financial institutions which we believe have sufficient credit quality to minimize the risk of loss
us-gaap Nonmonetary Transaction Amount Of Barter Transaction
NonmonetaryTransactionAmountOfBarterTransaction
0
CY2019Q1 us-gaap Nonmonetary Transaction Amount Of Barter Transaction
NonmonetaryTransactionAmountOfBarterTransaction
0
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1096791
CY2020Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.89
us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
2400000
pzg Net Proceeds From Issuance Or Sale Of Equity
NetProceedsFromIssuanceOrSaleOfEquity
2911286
CY2020Q1 pzg Concentration Of Credit Risk Uninsured Cash Amount
ConcentrationOfCreditRiskUninsuredCashAmount
1410000
CY2019 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
165505
us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
723279
CY2019 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
394785
CY2019 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
122406
CY2020Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
313340
CY2020Q1 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
216053
CY2019Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
868390
us-gaap Insurance Recoveries
InsuranceRecoveries
723279
us-gaap Insurance Recoveries
InsuranceRecoveries
391016
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
5631
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
5520
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
2591
CY2020Q1 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
10575
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
38288

Files In Submission

Name View Source Status
0001564590-20-022350-index-headers.html Edgar Link pending
0001564590-20-022350-index.html Edgar Link pending
0001564590-20-022350.txt Edgar Link pending
0001564590-20-022350-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pzg-10q_20200331.htm Edgar Link pending
pzg-20200331.xml Edgar Link completed
pzg-20200331.xsd Edgar Link pending
pzg-20200331_cal.xml Edgar Link unprocessable
pzg-20200331_def.xml Edgar Link unprocessable
pzg-20200331_lab.xml Edgar Link unprocessable
pzg-20200331_pre.xml Edgar Link unprocessable
pzg-ex311_9.htm Edgar Link pending
pzg-ex312_7.htm Edgar Link pending
pzg-ex321_8.htm Edgar Link pending
pzg-ex322_6.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending